Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations

Claudiani, S; Chee, L; Fernando, F; Brown, L; Achandira, UM; Khan, A; Rothwell, K; Hayden, C; Koutsavlis, I; Hannah, G; Innes, A; Apperley, JF; Milojkovic, D

Author(s): Claudiani, S; Chee, L; Fernando, F; Brown, L; Achandira, UM; Khan, A; Rothwell, K; Hayden, C; Koutsavlis, I; Hannah, G; Innes, A; Apperley, JF; Milojkovic, D;
Details: Publication Year 2024-06,Volume 99,Issue #6,Page 1172-1174
Journal Title: American Journal of Hematology
Publication Type: Research article
Abstract: Probability of treatment-free remission (TFR) in CML patients with additional chromosomal abnormalities (ACA) in the Philadelphia-positive clone or variant Philadelphia translocations (ACA/Var-Ph group, blue panel), in those with no cytogenetic abnormality other than the classical Philadelphia translocation (c-Ph group, green panel) and in the subgroups of CML patients with high-risk ACA (HR-ACA, yellow panel) and Var-Ph (red panel).
Publisher: Wiley
Keywords: Humans; *Translocation, Genetic; *Philadelphia Chromosome; *Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/drug therapy; Female; Male; *Remission Induction; Adult; Middle Aged; Chromosome Aberrations; Aged; Adolescent
Department(s): Clinical Haematology
Publisher's Version: https://doi.org/10.1002/ajh.27278
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-07-04 12:38:03

Last Modified: 2024-07-04 12:38:35